An easier way to manage diabetes and avoid long-term complications1
Dexcom G7 is the most accurate continuous glucose monitoring (CGM) system available2 and is covered for Medicare patients on all types of insulin.* Take control of your diabetes3-7 and improve your long-term health.1
To get started today, click on the link below or call 1-800-380-8244 to speak with a real person.
The #1 recommended CGM brand8,9 is covered by Medicare*
Dexcom G7 is now covered by Medicare for more people than ever.*
Medicare covers Dexcom G7 for people living with diabetes who are on any type of insulin. Even those who are not on insulin, but experience low blood glucose events, can qualify.
No other CGM system is more affordable than Dexcom G7 for Medicare patients.†,10
Easier diabetes management without fingersticks‡
Dexcom G7 is a real-time CGM system that sends your glucose numbers to your smartphone§ or Dexcom receiver without fingersticks.‡ An arrow shows the direction your glucose is heading—up, down, or steady. Because Dexcom G7 is proven to improve glucose control,3-7 it can help prevent long-term complications and improve your health.1
‡Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
Small wearable
Dexcom G7 is our smallest, most comfortable sensor yet.11 Most patients forget that they are even wearing it.12
Easy to use11
Dexcom G7 is easy to apply, easy to wear, and easy to use.11 See your glucose numbers in real time by simply glancing at your Dexcom receiver or smartphone.§
Lowers A1C3-7
Using Dexcom G7 is proven to lower A1C and help you spend more time in range,3-7 so you can do more of what you love.
“Before Dexcom G7, my glucose was unpredictable. Now I can see my numbers at a glance and take action in the moment. It has changed my life for the better, giving me more control over my diabetes and freedom to do what everyone else is doing!”
Pat G.
Dexcom user
Dexcom user
Simple alerts
Alerts warn you before you go too low or when you’re high, so you can make more informed glucose decisions.
Actionable insights
Get insight into how food and activity affect your glucose in real time, so you can make small changes that can help lead to big results.
Built-in support
Allow up to 10 people to see your glucose numbers on their smartphone§ for additional support and greater peace of mind.||
Learn more about your Dexcom receiver
Identify which Dexcom receiver you have below. Select the appropriate User Guide to learn how to set up your receiver or access the FAQs for more information.
“Before Dexcom G7, I would have to stop what I’m doing and fingerstick. With Dexcom G7, I can go sailing and motorcycle riding with no interruptions.‡ I’m finally back in control.”
Jimi H.
Dexcom user
Dexcom user
‡Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
“I spent years without a CGM and my A1C was going through the roof. I dreaded my doctor’s appointments. With Dexcom G7, my A1C is now down to 7! My doctor was so pleased, we were almost dancing.”
LeRae J.
Dexcom user
Dexcom user
Individual results may vary.
“Before Dexcom G7, it was a guessing game and a painful process of figuring out what I could eat. Now I can see how foods affect my glucose levels immediately. I’m happy that I can go back to my lifestyle.”
David P.
Dexcom user
Dexcom user
Get Started with Dexcom
Take the first step towards better health! Glucose health is a critical part of overall health, and Dexcom has the best sensing solution for you or your loved one regardless of your health goals. We'll make getting started easy from the comfort of your home.
If you are a Medicare beneficiary, you may be eligible for CGM coverage if you meet the following criteria:
- You have been diagnosed with diabetes
- Your provider has determined that you or their caregiver understands how to use CGM, and you have provided a prescription
- The CGM is prescribed in accordance with an FDA indication for its use
- You have been diagnosed with diabetes and meets one of the following criteria:
• You are treated with any insulin, or
• You have a history of problematic hypoglycemia, with documentation of at least of one following:
- One or more Level 2 hypoglycemic events (glucose <54mg/dL) that persist despite one or more modifications of the diabetes treatmentplan and/or adjustment of medication, OR
- One Level 3 hypoglycemic event (glucose <54mg/dL) characterized by altered mental and/or physical state requiring third-part assistance for treatment of hypoglycemia - You have an in-person or Medicare-approved visit with the practitioner prescribing the CGM within 6 months of initiating CGM therapy
- You have an in-person or Medicare-approved visit with the practitioner who prescribed the CGM every 6 months after initiating CGM therapy
Our experts are here to help.
*Medicare covers Dexcom CGM for insulin-requiring patients who meet the Medicare coverage criteria. For a list of Medicare coverage criteria, visit the Centers for Medicare and Medicaid Services website. Must meet eligibility requirements. †Under Medicare’s DME fee schedule, reimbursement, and coinsurance for CGMs using CPT codes A4239 and E2103 are the same, regardless of CGM brand. Regulation at 42 CFR 410.152(b), stipulates that coinsurance for items of durable medical equipment is 20% of the allowed amount. §Receiver is required to be used along with smart device in order to receive Medicare benefits for CGM. Compatible smart devices sold separately. To view a list of compatible smart devices, visit dexcom.com/compatibility. ||Separate Follow app and internet connection required.
1 The DCCT Research Group. N Engl J Med. 1993;329(14):977-86. 2 Dexcom, data on file, 2022. 3 Beck RW, et al. JAMA. 2017;317(4):371-378. 4 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 5 Martens T, et al. JAMA. 2021;325(22):2262-2272. 6 Gilbert TR, et al. Diabetes Technol Ther. 2021;23(S1):S35-S39. 7 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879. 8 dQ&A US Q1 2023 US Diabetes Connections Patient Panel Report. 2022; 104-105. 9 Seagrove HCP Survey Q2 2022; 23. 10 Managed Markets Insights & Technology, LLC. MMIT Analytics, June 2022. 11 Dexcom G7 CGM System User Guide. 2023. 12 Dexcom, data on file, 2020.
BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency. Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved. LBL-0000000 REV001